Authors


Elizabeth D. Hermsen, PharmD, MBA

Latest:

Pharmaceutical Companies and Antimicrobial Stewardship: Save Us a Seat

The pharmaceutical industry plays an essential role in advancing antimicrobial stewardship and addressing the growing threat of resistant pathogens.


Nicole Brandt, PharmD, MBA, BCPP, CGP, FASCP

Latest:

A Long-Term Care Antimicrobial Stewardship Certificate Program for Pharmacists: Filling an Unmet Need

This training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.


Kim Claeys, PharmD

Latest:

Novel Cephalosporin Agent Shows Promise for Complicated UTIs

A new agent in the antibiotic pipeline, cefiderocol, has proved to be effective against complicated urinary tract infections (UTIs).


MONIQUE A. FOSTER, MD, MPH

Latest:

Hepatitis A Outbreaks on the Rise in the US

An epidemiologist explores the changing epidemiology of a familiar disease.


Laurie Anne Walden, DVM, ELS

Latest:

Psychobiotics: What Do We Know and Where Do We Go?

Review authors discuss current knowledge regarding psychobiotics and identify questions for future research.


Jamie Kisgen, PharmD, BCPS-AQ ID

Latest:

Staying Ahead of the Curve: Implementing AUC-Guided Vancomycin Dosing

Evidence suggests AUC-guided vancomycin dosing is a safer method than traditional trough-guided dosing.


Einav Keet

Latest:

An Estimated 5700 Zika Cases Went Unreported in 2017 Cuban Outbreak

Although Cuba reported no cases of Zika virus in 2017 and 2018, investigators used travel data and genomic epidemiology to uncover a large, “hidden” Zika outbreak.


Danielle Mroz

Latest:

SEP-1 Bundle Compliance Associated with Reduced Hospital Readmissions

As the leading cause of unplanned 30-day hospital readmissions, sepsis affects more than 1.5 million individuals each year.


Brendan R. Jackson, MD, MPH

Latest:

Candida auris: Coming Soon to a Facility Near You?

Epidemiologic and clinical lessons for the uninitiated.



MARLEE A. MANGINO, PHARMD

Latest:

Transition to Oral Therapy for the Treatment of Bacteremic Urinary Tract Infections

Several recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.


Adriano de Bernardi Schneider, MS

Latest:

Phylogenetically Mapping the Evolution of the Zika Virus as It Spread Across the World

Adriano de Bernardi Schneider, MS, PhD Candidate, Contagion® Editorial Advisory Board Member, provides a brief snapshot into some of his work on mapping the evolution of the Zika virus.


BY DEBRA GOFF, PHARMD**

Latest:

Teaching Old Dogs New Tricks: Make the Most of Twitter to Boost ID Education, Engagement, and Advocacy

Infectious diseases clinicians turn to Twitter as a tool for education and collaboration.



Thy N. Le, PharmD, BCPS-AQ-ID

Latest:

Update on Candida auris: Statistics, Detection, and a Phase 2 Trial

As of October 31, 2018, the CDC has reported 457 clinical cases of confirmed C auris infection with a majority in New York (>50%), New Jersey, and Illinois.


MARILYN MOOTZ, PHARMD

Latest:

Long-Acting Anti-MRSA Agents: One Dose to Cure?

A review of the current literature and future directions.


Paul E. Sax, MD

Latest:

Addressing Suboptimal Treatment Response in HIV

A panel of experts on HIV discuss decision-making practices for patients who have suboptimal response to their current treatment regimen.


Grant M. Gallagher

Latest:

Texas State Scientist on Rabies Eradication, Campus Reopening, and AMR

Dr. Rodney E. Rohde, clinical laboratory scientist, discusses campus reopening as well as his work on rabies eradication.


William Barany, PharmD

Latest:

Candida Auris: The Rise of a New Fungal Threat

Candida auris—Are we prepared for another multidrug-resistant pathogen?


LACEY AVERY, MA

Latest:

Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest Report

A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.


J. NICHOLAS O

Latest:

Transition to Oral Therapy for the Treatment of Bacteremic Urinary Tract Infections

Several recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.


EMILY HEIL, PHARMD, BCPS-AQ ID

Latest:

Globalization of Antibiotic Stewardship Programs: The World Is Waiting

The globalization of antibiotic stewardship programs is necessary in the fight against antibiotic resis­tance.


Shirley M. Mueller, MD

Latest:

Suffering through COVID-19: A Doctor's Personal Journey

Frontline health care workers had a nearly 12 times higher risk of testing positive for COVID-19 compared with individuals in the general community.


LUCIA ROSE, PHARMD

Latest:

Hospital-Acquired and Ventilator-Associated Pneumonia: Highlights and Pitfalls of the 2016 IDSA / ATS Guidelines

Hospital-acquired and ventilator-associated pneumonia account for 22% of all hospital-acquired infections.



Christina G. Rivera, PharmD, BCPS

Latest:

ID Consultation Associated With Reductions in ED Visits, Hospital Admissions, and Cost for OPAT Patients

This In the Literature piece details a study evaluating the effects of ID consultation for OPAT patients.


KAITE KAMMERS, PHARMD, BCPS

Latest:

Exploring Primary Prophylaxis for Invasive Pulmonary Aspergillosis

Invasive aspergillosis affects up to 13% of immunocompromised patients who are in the hospital.


YASIR AL-KHALILI, MD

Latest:

Searching for the Cause of Hearing Loss in a Patient With HIV

Early diagnosis and treatment were essential to ensuring a good prognosis.


Joseph DeRose, DO

Latest:

Doravirine: Researchers DRIVE for a Drug Ahead of Its Class

A novel NNRTI hits the market, but what place will it have in treatment?


Amanda Warren

Latest:

Aging HIV-Infected Population Faces Unique Challenges

As the population of people living with HIV infection is living longer, age-related health issues are affecting these individuals in an accelerated or emphasized fashion.

© 2024 MJH Life Sciences

All rights reserved.